Introduction
Overview
While there is evidence to support that interventions involving self-management of chronic diseases by patient empowerment are effective [-], with an increasingly used modality being telehealth interventions, the flip side of…

While there is evidence to support that interventions involving self-management of chronic diseases by patient empowerment are effective [-], with an increasingly used modality being telehealth interventions, the flip side of…

A trial of more than 3,000 healthy full-term infants shows clesrovimab, a single-dose monoclonal antibody, reduced the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infection and RSV-associated…

Xavier Leleu, MD, PhD, head of the department of hematology and myeloma clinic at Hôpital La Mileterie in Poitiers, France, sat down with Pharmacy Times® at the 22nd annual International Myeloma Society (IMS) meeting and exposition in Toronto,…

A central tension in contemporary AI governance debates concerns the perceived trade-off between advancing innovation and ensuring safety and security. AI safety, which concerns preventing harm from advanced systems ranging from…

Amazon went to trial on Monday in a US government lawsuit that accuses the e-commerce giant of using tricks to enroll millions of customers in its Prime subscription service and then making it nearly impossible to cancel.
The Federal Trade…

This article first appeared on GuruFocus.
Sep 22 – IREN Limited (NASDAQ:IREN) has taken another big step in its push into artificial intelligence infrastructure.
On Monday, the data center operator and bitcoin miner said it will spend…

Satellos submits SAT-3247 IND to FDA for phase 2 study in children with Duchenne muscular dystrophy | Image credit: Contemporary Pediatrics
On September 22, 2025, Satellos Bioscience submitted an Investigational New Drug (IND) application to the…

Induction and consolidation with daratumumab (Darzalex), lenalidomide (Revlimid), and carfilzomib (Kyprolis) plus dexamethasone (Dara-KRd) followed by daratumumab/lenalidomide maintenance exhibited prolonged progression-free survival (PFS) in…